# Telerehabilitation Alzheimer's Disease Feasibility (TADF)

> **NCT04732182** · NA · UNKNOWN · sponsor: **Bright Cloud International Corp** · enrollment: 14 (estimated)

## Conditions studied

- Alzheimer Disease
- Healthy Aging

## Interventions

- **DEVICE:** BrightGo cognitive training
- **DRUG:** Standard of Care medication for early Alzheimer's Disease

## Key facts

- **NCT ID:** NCT04732182
- **Lead sponsor:** Bright Cloud International Corp
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-16
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-02-28
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732182, "Telerehabilitation Alzheimer's Disease Feasibility (TADF)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04732182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*